CareDx, Inc.
69.21USD
+0.0500 (+0.07%)
Fetching financial statements from SEC filings…
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on CDNA.
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* | Q3 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 132 | 118 | 108 | 100 | 87 | 85 | 87 | 83 |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Operating Income | 113 | 1 | -6 | -0 | -11 | -13 | 84 | -14 |
| Net Income | 111 | 3 | -4 | 2 | -9 | -10 | 88 | -11 |
| EPS (Diluted) | $2.07 | $0.05 | -$0.08 | $0.03 | -$0.16 | -$0.19 | $1.60 | -$0.20 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)